Posted on February 2, 2016 by Sitemaster
Some 2½ years ago, James presented data from the TRAPEZE trial at the annual meeting of the American Society of Clinical Oncology in Chicago. At the time, we described these data as “unsurprising.” … READ MORE …
Filed under: Management, Treatment | Tagged: catration-resistant, docetaxel, mCRPC, metastatic, outcome, strontium-89, TRAPEZE, zoledronic acid | Leave a comment »
Posted on June 2, 2013 by Sitemaster
The only late-breaking, prostate cancer-specific paper to be presented at the annual meeting of the American Society of Clinical Oncology (ASCO) this year was from the TRAPEZE study carried out in the UK. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: castration-resistant, chemotherapy, docetaxel, mCRPC, metastatic, strontium-89, TRAPEZE, zoledronic acid | 2 Comments »
Posted on November 19, 2011 by Sitemaster
A new article on the OncologySTAT web site provides a summary of a presentation by Alain Pecking, MD, from the annual meeting of the International Society for Geriatric Oncology. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: bone, metastasis, outcome, pain, radionuclide, strontium-89 | 1 Comment »
Posted on January 2, 2009 by Sitemaster
Today’s news report contains items on:
- The estimation of localized prostate cancer tumor size based on PSA data alone
- Mitochondrial genes and prostate cancer risk
- Results of a Phase II trial of strontium-89 with chemohormonal therapy in men with metastatic bone disease
- The association between spirituality and quality of life in low-income patients with metastatic disease
We have provided separate reports on the results of a clinical trial of flaxseed in men diagnosed with prostate cancer pre-treatment and on the 5-year outcomes of younger men treated with brachytherapy as first-line therapy for localized prostate cancer. … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: chemohormonal therapy, HRQOL, mitochondrial genes, quality of life, spirituality, strontium-89, tumor size | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 